REVENUES

6 Months Ended

Jun. 30, 2023

REVENUES

REVENUES

NOTE 4 – REVENUES

The following table summarizes the Company’s disaggregation of revenues:

	Three Months Ended June 30,				Six Months Ended June 30,
(U.S. dollars in thousands)	2023		2022		2023		2022
Pfizer	$	3,402	$	3,382	$	5,668	$	6,738
Brazil	$	—	$	—	$	2,800	$	5,454
Chiesi	$	11,673	$	—	$	11,673	$	218
Total revenues from selling goods	$	15,075	$	3,382	$	20,141	$	12,410
Revenues from license and R&D services	$	20,000	$	5,371	$	24,522	$	12,428